Fresenius Medical Care layoffs, on the record
Every job cut, severance charge and restructuring Fresenius Medical Care reported in its annual reports, 2023 to 2025, quoted from the filings. Headcount went from 119,845 to 109,698.
Headcount, as reported
| Annual report | Employees | As of |
|---|---|---|
| 20-F for 2023 | 119,845 | December 31, 2023 |
| 20-F for 2024 | 111,513 | December 31, 2024 |
| 20-F for 2025 | 109,698 | December 31, 2025 |
Job cuts, severance and restructuring
Our summaryHeadcount fell 6% in 2023, largely due to divestitures of certain businesses under the Legacy Portfolio Optimization and FME25 Programs and lower production activities partly tied to FME25.
Word for word“This 6% decrease was largely due to the divestiture of certain businesses, including NCP and our service businesses in Argentina and Hungary, in connection with the Legacy Portfolio Optimization program and the FME25 Program as well as lower production activities (partly as a result of the FME25 Program).” 20-F for 2023
Our summaryExpenses from strategic transactions and programs, including divestitures and impairments tied to Legacy Portfolio Optimization and the FME25 Program, were recorded in other operating expense.
Word for word“Included within the “expenses from strategic transactions and programs” line item in other operating expense are the completed and proposed divestitures (including associated impairment losses) of certain businesses in connection with strategic programs such as Legacy Portfolio Optimization, defined below, and the FME25 Program and, in 2022, costs related to the InterWell Health business combination.” 20-F for 2023
Our summaryHeadcount decreased 7% largely due to the divestiture of certain businesses in connection with Legacy Portfolio Optimization.
Word for word“We employed 111,513 people (total headcount) as of December 31, 2024 (December 31, 2023: 119,845).” 20-F for 2024
Our summaryCompany reported gains and expenses from strategic transactions and programs, including Legacy Portfolio Optimization divestitures, but no specific layoff or severance program was stated.
Word for word“Included within the “income from strategic transactions and programs” line item in other operating income are the gains from divestitures of certain businesses in connection with strategic programs such as Legacy Portfolio Optimization, defined below.” 20-F for 2024
Our summaryThe company divested certain businesses under its Legacy Portfolio Optimization program, which lowered total headcount by about 2% in 2025.
Word for word“We employed 109,698 people (total headcount) as of December 31, 2025 (December 31, 2024: 111,513).” 20-F for 2025
Fresenius Medical Care has filed no restructuring notice (Form 8-K, Item 2.05) since 2016. Companies file one only for a cut they judge material, so many announced layoffs never appear as one. This page shows what the company reported to the SEC, not news reports or state layoff notices.
Read from Fresenius Medical Care’s annual reports (20-F for 2025, 20-F for 2024, 20-F for 2023) and the financial data it files with the SEC, as of 2026-02-24. Every quotation is word for word from the filing linked beside it; how these pages are built and checked. The full record is in its company data sheet.